Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine Monotherapy in Refractory Bipolar Mania
NCT00194064Phase 3Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jul 2002
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of olanzapine in bipolar I disorder, sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Young Mania Rating Scale. Started Jul 2002; status: terminated.
02
Drugs
olanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00194064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194064.